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Anxiety comprises many clinical descriptions and pheno-
types. A genetic predisposition to anxiety is undoubted;
however, the nature and extent of that contribution is still
unclear. Methods for the genetic analysis of such complex
disorders is briefly reviewed, followed by a discussion of
the comorbidity of anxiety with other psychiatric disorders
and their possible common genetic etiology. Extensive
genetic studies of the serotonin (5-hydroxytryptamine,
5-HT) transporter (5-HTT) gene have revealed how varia-
tion in gene expression can be correlated with anxiety
phenotypes. Complete genome-wide linkage scans for
panic disorder (PD) susceptibility genes have suggested a
locus on chromosome arm 7p, and association studies have
highlighted many candidate genes. A highly significant
association between phobias, panic disorder, and a dupli-
cation at chromosomal region 15q24-26 is one of the most
exciting findings to date. Emerging molecular genetic
technologies and the use of increasingly sophisticated
animal models of anxiety provide great promise for the
future of the field. 
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nxiety is part of the normal human experience.
We may speculate that it served human survival during
evolution by enhancing preparedness and alertness.
However, anxious manifestations are abnormal when
they are exaggerated in excess of any objective danger
that the individual is facing, when they induce psycho-
logical distress or physical ailments, or when they are
self-aggravating in a vicious circle.As a subject of clinical
diagnosis, anxiety may be chronic, for instance, in some
types of personality disorder or in generalized anxiety
disorder (GAD); in such cases, it is akin to a “trait.” In
other instances,anxiety is a short-lived,noncontinuous,
discrete symptom, for example, in panic disorder (PD)
or in acute stress;then it is a “state,”rather than a trait.
Anxiety comprises many phenotypes and clinical
descriptions.It is routinely partitioned into disorders of
general anxiety, panic, phobia, and in some classifica-
tions, obsessive-compulsive disorder (OCD); and the
lifetime prevalence for the group of disorders has been
estimated to be as high as 25%.
1 Even this classification
does not go far to encompass the complexity of anxiety,
and hence the arduousness of the task of getting at its
biological root.The success to date has not been over-
whelming;however,some recent studies have provided
more hope than was in the past thought to be realistic.
OCD is sometimes classified with anxiety (eg, in the
Diagnostic and Statistical Manual of Mental Disorders
[DSM]) and sometimes not (eg, in the International
Statistical Classification of Diseases,10th Revision [ICD-
10]). Attempts to unravel the genetics of OCD are
numerous and would be best served in a treatise of their
own, and so will not be included in this review. Since
many genetic studies on anxiety have been performed
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(e-mail: morrisro@ukl.uni-freiburg.de)on PD and, possibly as a direct result thereof, the most
enlightening results to date have been found for PD, a
proportionate amount of this review will concentrate on
the findings in PD.The aim of this review is by no means
to overstate the role of genetics in anxiety, rather to
highlight the evidence that exists for the role of genetics
in anxiety.
The term “complex trait”has been coined by geneticists
to refer to any phenotype that does not exhibit classic
mendelian recessive or dominant inheritance attribut-
able to a single gene.
2 In general, complexities arise
when the simple correspondence between genotype and
phenotype breaks down,because either the same geno-
type can result in different phenotypes (due to the
effects of chance, incomplete penetrance, environment,
or interactions with other genes),or different genotypes
can result in the same phenotype (eg, phenocopies, due
to environmental or random causes).In fact,most traits
of medical relevance,and particularly psychiatric disor-
ders,do not follow simple mendelian inheritance.During
the last decade, geneticists have taken up the challenge
of the genetic dissection of complex traits.
The usual path taken to the elucidation of the genetic
basis of psychiatric and other complex disorders is
becoming fairly routine. Before undertaking studies
aimed at genetic dissection,particularly at the molecular
or DNA level,one would ideally like to infer as much as
possible about the genetic basis of the trait on the basis
of the pattern of disease incidence in families and pop-
ulations.Hence,first we need evidence for a genetic com-
ponent to anxiety.A genetic contribution to psychologi-
cal traits and psychiatric disorders is not in doubt,but the
nature and extent of that contribution is still unclear.
Genetic epidemiology has assembled convincing evi-
dence that anxiety and related disorders are influenced
by genetic factors and that the genetic component is
highly complex.While studies of the patterns of inheri-
tance of personality indicate that various dimensions are
likely to be influenced by many genes and quantitative
traits,it also documents the significance of environmen-
tal factors.As the modes of inheritance of anxiety disor-
ders are complex, it has been concluded that multiple
genes of small effect,in interaction with each other and
with nongenetic neurodevelopmental events, produce
vulnerability to the disorder.
Segregation analysis involves fitting a general model to
the inheritance pattern of a trait in pedigrees.The only
opportunity to examine the expression of a human trait
in a fixed genetic background comes from the study of
monozygotic (MZ) twins.
3 The absolute risk to an MZ
twin of an affected individual provides a direct estimate
of penetrance for a given environment.Twin studies gen-
erally compare the similarity between identical (MZ)
and fraternal (dizygotic [DZ]) twins.DZ twins share on
average only half of their genes, as do normal sibs.A
higher correlation between MZ than between DZ twins
indicates a genetic influence on the trait under investi-
gation.Twin studies of self-reported symptoms of anxi-
ety, often called negative emotionality or neuroticism,
consistently indicate that approximately 50% of the vari-
ance can be attributed to genetic factors.
4-6
Tools of the trade
The methods available for the genetic dissection of com-
plex traits, which will be referred to at various stages
throughout this review,are linkage analysis,allele-sharing
methods,association studies in human populations,and
genetic analysis of large crosses in model organisms such
as the mouse.For the purposes of this review,I will briefly
summarize the methods;however,more detailed accounts
abound in the literature.
2,6,7 Linkage analysis is a form of
genetic mapping that is used to find the approximate
chromosomal location of a putative gene.Linkage studies
are based on the identification of large families with many
affected members and one is required to specify a mode
of inheritance for the disorder.The inheritance of the dis-
order in the family is then compared with the allelic
inheritance of known sections of DNA known as poly-
morphic markers.The coinheritance,or linkage,of a par-
ticular marker allele with the presence or absence of the
disorder allows one to define or narrow down the loca-
tion of the suspected gene.Thus,linkage analysis allows
one to find out where a gene is,without knowing what it
is.A gene can then be isolated,based solely on its chro-
mosomal location,without regard to its biochemical func-
tion,this being known as “positional cloning.”
8
Basic research
252
Selected abbreviations and acronyms
AR adenosine receptor
DZ dizygotic
GAD generalized anxiety disorder
5-HT 5-hydroxytryptamine (serotonin)
5-HTT 5-hydroxytryptamine transporter
MZ monozygotic
PD panic disorderIn allele-sharing methods of analysis,one checks whether
or not the inheritance pattern of a chromosomal region
is consistent with random mendelian segregation.If not,
patients and their affected relatives will inherit identical
copies of DNA markers within that chromosomal region
more often than expected by chance. Since allele-shar-
ing methods are nonparametric (that is,they assume no
model for the inheritance of the trait),they tend to be
more robust than linkage analysis,particularly for com-
plex disorders, for which the inheritance pattern is not
clear.Association studies are case-control studies based
on a comparison of unrelated affected and unaffected
individuals from a population. An allele of a gene of
interest is said to be associated with the trait if it occurs
at a significantly higher frequency among affected com-
pared with control individuals.Familial inheritance pat-
terns are irrelevant to the method, however, the choice
of the control group and its match to the patient group
is vital to the study. Population associations between a
genetic marker and a phenotypic trait can arise either
from population stratification (ie,ethnic differences,and
hence different allele frequencies between populations)
or genetic transmission. A refinement of association
studies is to use family trios (a patient and his or her par-
ents) or sibling pairs, in an attempt to eliminate prob-
lems of population stratification. Association studies
have most been applied to genes or DNA markers
linked to genes proposed as candidates for a particular
trait. Experimental crosses of mice and rats offer an
ideal setting for the genetic dissection of mammalian
physiology.With the opportunity to study hundreds of
meioses from a single set of parents, the problem of
genetic heterogeneity disappears,and far more complex
genetic interactions can be probed than would be possi-
ble in human families.Animal studies relating to anxiety
will be described in more detail in the final section of
this review.
One way to undertake genetic studies of psychiatric ill-
ness is to find a classification that might relate more
directly to the inheritance pattern.The ideal would be to
find pedigrees in which the disorder segregates in a
strictly mendelian fashion, as a recessive or dominant.
Although these families may not be phenotypically typ-
ical of the disorder,there would be good chance of find-
ing genetic linkage and the first step towards isolating
an abnormal gene.This gene and its product may pro-
vide a clue as to the type of pathway or mechanism caus-
ing the disorder. Unfortunately, such families are not
abundant. An alternative is to find other genetically
determined features that predispose to psychiatric ill-
ness, for example, the deletion of chromosomal region
22q11 has been shown to be associated with an increased
risk of developing a psychotic illness.
9 The recent find-
ings of the duplication of part of chromosome 15 in
patients with anxiety disorders,
10 described later in this
review,has caused great excitement and hope for workers
in the field.
Comorbidity of anxiety with other 
psychiatric disorders
The comorbidity of anxiety disorders with each other
and with other psychiatric disorders,
11 particularly
mood,
12 has been observed and accepted for many
decades.It is known that patients with major depression
invariably show either syndromal comorbidity of one or
another anxiety disorder or clinically significant severity
of anxiety symptoms.
13Also,the efficacy of many major
psychotropic drugs in the treatment of depression and a
broad spectrum of anxiety disorders,eg,GAD,PD,social
anxiety disorder, and posttraumatic stress disorder
(PTSD),is well established.However,wherever possible,
mood and anxiety have been separated and delineated
into different disorders.
Evidence for a common genetic etiology for bipolar dis-
order and PD came from a family study
14 in which an
unusually high prevalence of PD in 57 families with high
rates of bipolar disorder was reported. Families at high
risk of PD showed linkage to markers on the long arm
of chromosome 18 (18q), whereas families of probands
without PD did not.This led the authors to conclude that
there may be a genetic subset of patients with bipolar
disorder who had comorbid PD.These results were very
recently extended and confirmed by the same group in
an independent group of bipolar disorder families.
15 In
the same recent issue of the American Journal of
Psychiatry,Rotondo and colleagues
16 conducted a case-
control association study of the genetic polymorphisms
of three monoamine neurotransmitter system candidate
genes,catechol-O-methyltransferase (COMT),serotonin
(5-hydroxytryptamine or 5-HT) transporter (5-HTT),
and tryptophan hydroxylase (TPH), in patients with
bipolar disorder with and without lifetime PD.
Remarkably, the patients with bipolar disorder without
PD showed significantly higher frequencies of the
COMT Met158 and the short 5-HTTLPR alleles and
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253genotypes.These results suggest that bipolar disorder
with and without comorbid PD represent distinct genetic
forms,although no single genetic model could be applied
to the subset of families with PD. The boundaries
between the bipolar/panic phenotype remain obscure,
and the question arises as to whether the bipolar/panic
phenotype includes individuals with panic attacks below
the threshold for a diagnosis of PD.
15 Thus, it is still not
clear whether panic vulnerability in families with a high
prevalence of bipolar disorder is the result of general
nongenetic activation of anxiety mechanisms,a specific,
partially penetrant gene,or a combination of genes.
15
GAD,which is usually classified under the anxiety spec-
trum disorders, is defined by excessive and uncontrol-
lable worry about a number of life events or activities
for at least 6 months, accompanied by at least three of
the following six associated symptoms of negative effect
or tension: restlessness, fatigability, concentration diffi-
culties, irritability, muscle tension, and sleep distur-
bance.
17Twin and family-based studies have indicated a
clear genetic influence in GAD with a heritability of
approximately 30%; however, Kendler et al
18,19 found
that GAD-associated genetic factors were completely
shared with depression, while environmental determi-
nants seemed to be distinct.GAD is associated with high
comorbidity rates for other psychiatric disorders,includ-
ing PD, major depression,dysthymia,social phobia,and
specific phobia.
20-24 This notion is consistent with recent
models of emotional disorders that view anxiety and
mood disorders as sharing common vulnerabilities, but
differing on dimensions including,for instance,focus of
attention or psychosocial liability.
25
Anxiety as a behavioral trait
Anxiety-related traits are fundamental, enduring, and
continuously distributed dimensions of normal human
personality.
26,27 Attempts to dissect out anxiety-related
personality traits, including fearfulness, emotional sta-
bility, and stress reactivity, and to measure their heri-
tability, are possibly the most difficult and definitely
amongst the most contentious.The analysis of genetic
contributions to anxiety-related or aggressive behavior
is both conceptually and methodologically difficult, so
that consistent findings remain sparse. Mood, anxiety,
emotion, and cognition are modulated by the seroto-
nergic midbrain raphe system, and a dysregulation of 
5-HTT expression might be important in the course of
these disorders.
28Transporter-facilitated uptake of 5-HT
has been implicated in anxiety in human and animal
models and is the site of action of widely used uptake-
inhibiting antidepressant and antianxiety drugs. The
5-HTT terminates the synaptic actions of 5-HT by
sodium-dependent reuptake of 5-HT into the presynap-
tic vesicles.Heils et al
29 isolated and cloned the 5´-regula-
tory region of the 5-HTT gene, SLC6A4, which is
located on chromosomal region 17q12. Systematic
screening for length variations and functional promotor
analyses revealed a genetic polymorphism that shows
allelic variation in transcriptional activity and protein
expression.
30 The short variant of the polymorphism
reduces the transcriptional efficiency of the 5-HTT gene
promotor,resulting in decreased 5-HTT expression and
5-HT uptake in lymphoblasts.Extensive genetic studies
of the 5-HTT gene have revealed how variation in gene
expression can be correlated with anxiety phenotypes.
Association studies in two independent population and
family-based samples,totaling 505 individuals,revealed
that the 5-HTT polymorphism accounts for 3% to 4%
of total variation and 7% to 9% of inherited variance in
anxiety-related personality traits in individuals as well
as sibships.
31 Using three different personality assess-
ment scales, the results showed that the 5-HTTLPR
influences a constellation of traits related to anxiety.
Lesch et al
31 stressed that the associations reported by
them represent only a small portion of the genetic con-
tribution to anxiety-related personality traits,and that if
other genes were hypothesized to contribute similar
gene dosage effects to anxiety, approximately 10 to 15
genes might be predicted to be involved.
Panic disorder
Probably the most genetic studies of anxiety have been
conducted on patients with PD. PD typically has its
onset between late adolescence and the mid-30s, and is
strikingly different from other types of anxiety in that
the panic attacks are sudden,appear to be unprovoked,
and are often disabling.The first attacks are frequently
triggered by physical illnesses,psychosocial stress,or cer-
tain drug treatments or drugs of abuse that increase the
activity of neural systems involved in fear responses.
Panic attacks respond to a variety of antidepressant
drugs,they can be precipitated pharmacologically by car-
bon dioxide (CO2), caffeine, lactate, cholecystokinin
tetrapeptide,
32 and serotonergic compounds
33;and func-
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254tional imaging studies have identified neurological cor-
relates of attacks.
34-36All of these observations speak for
a physiological vulnerability.Sensitivity to CO2 and lac-
tate may indicate a distinct genetic liability.
37-39 Candidate
genes for association studies in PD have often been
selected on the basis of the molecular mechanisms of
drugs utilized in challenge tests, such as m-chloro-
phenylpiperazine (mCPP),a nonselective 5-HT2C recep-
tor agonist.
40The enhancement of GABAergic (GABA,
γ-aminobutyric acid) neurotransmission has been closely
linked to antipanic drug efficacy.
Hettema et al
41 recently published the results of meta-
analysis of selected epidemiological studies, in order to
summarize and quantify the information gathered to
date on the familial aggregation of anxiety disorders 
and the relative contributions of genetics and environ-
ment to their etiology.Five family studies of PD,all from
clinical populations that met their inclusion criteria,were
included in the meta-analysis.All five studies supported
the familial aggregation of PD,with a significant associ-
ation between PD in the probands and PD in first-
degree relatives.The unadjusted aggregate risk based on
1356 total first-degree relatives of PD probands was
10%,compared with 2.1% in 1187 comparison relatives.
Small twin studies of PD by Torgersen
42,43 have found
concordance rates of 22% to 31% for MZ twins and 0%
for DZ twins. In an enlarged sample, the same group,
using DSM-III-R criteria, found concordance rates of
25% for MZ twins and 10% for DZ twins.
44A large pop-
ulation-based twin study of PD in women found a 24%
MZ concordance and 11% DZ concordance using a
“narrow clinician’s”diagnosis.
45The estimate of narrow-
sense (additive) heritability of PD using this diagnosis
was 46%.This is similar to what has been observed for
the other anxiety disorders.Interestingly,the subdivision
of PD patients according to age of onset before or after
20 years of age led to remarkable differences in risk of
22% and 8%, respectively. This indicates a much
stronger genetic component in early-onset PD as
opposed to late-onset PD;a finding consistent with other
complex disorders,for example,Alzheimer’s disease and
breast cancer, which are rendered genetically more
homogeneous when focusing on early-onset cases.
46,47
Models for the mode of inheritance of PD remain highly
speculative. Some segregation analyses have suggested
the involvement of a major gene,
48,49 other studies have
provided equal support for both recessive and dominant
genetic models.
50,51 Two complete genome-wide linkage
scans for PD liability genes have been published.
52,53
Knowles et al
52 genotyped up to 23 families with many
affected individuals,with 540 microsatellite DNA mark-
ers. Since their previous studies had indicated that a
large number of PD cases in the general population are
likely to be phenocopies,
50,51 they included phenocopies,
reduced penetrance, and “unaffected” individuals in
their analysis. Six DNA markers, on chromosomal
regions 1, 7, 17, 20p, and 20q (short and long chromo-
some arms, respectively) and X and Y gave promising
lod scores (>1); however, no markers gave lod scores
that exceeded the significant threshold of 3.3 suggested
for declaring linkage to a complex trait in a genome
scan.
7 In the more recent study of Crowe et al,
53 in which
they genotyped 23 multiply affected families with a dif-
ferent set of 469 markers,the highest lod score obtained
(2.23) was for a marker on the short arm of chromosome 7
(7p15),within the same region (within 10 cM) of one of
the markers to which Knowles et al
52 had detected pos-
sible linkage.This replication of a previous finding adds
importance to the result,and interesting candidate genes
in this region have been highlighted.The corticotropin-
releasing hormone receptor 2 locus maps between the
two markers that showed possible linkage on 7p, and
mouse knockouts for this gene have shown increased
anxiety-related behaviors.
54 Similarly,the elastin gene is
located within the region of possible linkage,and is also
of interest because of the prevalence of joint hypermo-
bility in patients with PD, which is discussed in a sepa-
rate section below.
In addition to the linkage studies in PD, a number of
candidate, or putative vulnerability, genes have been
assessed in association studies. A role of monoamine
neurotransmitters in the etiology of PD has been sug-
gested by the observation that increased serotonergic
neurotransmission provokes anxiety even up to the level
of panic attacks in PD patients
33 and that decreased 
5-HT uptake is found in patients with anxiety disorders.
55
Although it could be hypothesized that enhanced sero-
tonergic neurotransmission in PD is due to increased 
5-HT,no association with 5-HTTLPR-dependent varia-
tion in 5-HTT expression and PD was detected in dif-
ferent populations.
56-58 Monoamine oxidase A (MAOA),
an enzyme involved in the degradation of 5-HT and nor-
epinephrine and thus positioned at the crossroads of two
monoaminergic systems, is another plausible candidate
gene.
25A 30-bp repeat polymorphism was recently iden-
tified in the promotor region of the MAOA gene that
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255differentially modulates gene transcription.
59 Variation
in the number of repeats in the MAOA polymorphic
region showed allele-dependent transcriptional effi-
ciency,with the effectiveness of the 3-repeat allele being
two times less than alleles with longer repeats.
An association study in two independent samples of 
209 individuals revealed that longer alleles were signifi-
cantly more frequent in female patients than controls.
Considering that the inhibition of MAOA is clinically
effective in the treatment of PD,particularly in women,
these findings suggest that altered MAOA activity may
be a gender-specific risk factor for PD.
Caffeine, an adenosine receptor (AR) antagonist,
induces panic attacks in patients with the disorder
60 and
caffeine intoxication (DSM-III-R) resembles anxiety dis-
orders.Adenosine analogues have depressant effects on
respiratory function in the brainstem,and an impairment
of depressant brainstem respiratory mechanisms are
considered a central feature in PD.
61 These and other
observations have led to the hypothesis that the effec-
tiveness of adenosinergic neuromodulation in patients
with PD may be impaired due to changes in receptor
function. Four different human AR subtypes have thus
far been identified,the A1 and A2a of which mediate the
central nervous system effects of adenosine.Deckert et
al
62 systematically searched for mutations in the A1 and
A2a genes in patients with PD and, although only silent
mutations or polymorphisms were found, a significant
association between an A2aAR polymorphism and PD
was found. This polymorphism must not be directly
involved in the etiology of PD,but may be in linkage dis-
equilibrium with a true functional variant either in this
or a nearby gene. Further evidence for involvement of
ARs in anxiety has been provided in mouse models.
Mice in which the A2a or A1 receptors had been dis-
rupted or “knocked out” scored higher in anxiety tests,
and male A2aR
-/- mice (homozygous A2aR knockout
mice) were much more aggressive towards intruders.
63,64
Phobias
Kendler et al
65 investigated the reliability and herita-
bility of unreasonable fears and phobias in a population-
based sample of 1942 female twins. Phobia was defined
as the presence of a fear that the respondent recognized
as unreasonable and that, in the judgment of the inter-
viewer,objectively interfered with the respondent’s life.
Unreliability occurred both for subject recall of unrea-
sonable fears and for interviewer assessment of which
fears constituted phobias.When fears and phobias were
examined together in a multiple threshold model, their
results suggested that the resemblance between twins
was due solely to genetic factors, with estimated total
heritabilities,after correction for unreliability,of 43% to
67%, with the latter highest value for agoraphobia.
These authors concluded that individual-specific envi-
ronmental experiences play an important role in the
development of phobias, while familial–environmental
factors appear to be of little etiological significance.
These “phobia-genic”experiences are,apparently,rarely
shared with a cotwin.
Only few population-based association and linkage-dis-
equilibrium studies have been conducted for phobias,
with few really promising results, which therefore will
not be listed in this review.However,very recently,pos-
sibly one of the most exciting genetic studies in anxiety
to date has been reported by the group of Estivill,
10 who
found an association between the duplication of part of
chromosomal region 15q24-26 and irrational fears, or
phobias. One of the major uncertainties of the study is
the phenotypic classification of the patients;the authors
apparently lump panic and phobic disorders together
and do not include a detailed clinical description of the
patients. For this reason, as well as the importance and
hope that their findings provide for the field as a whole,
the study deserves a section of its own.
The chromosome 15 connection
Among the biological variables studied in PD, joint 
laxity or joint hypermobility syndrome has yielded 
particularly interesting results. Joint laxity is a clinical
condition characterized by an increased distensibility
and hypermobility of joints.It has a female-to-male ratio
of 3:1, a dominant pattern of inheritance, and a preva-
lence of 10% to 15%.
66 Joint laxity is a feature common
to several hereditary diseases of the connective tissue,
and has also been significantly associated with mitral
valve prolapse,
67 but a specific joint laxity gene has not
been identified.Strong associations between joint laxity,
mitral valve prolapse, and anxiety disorders have been
described.
68-71 On the basis of a case-control study in
rheumatology patients,
68 it was reported that PD,agora-
phobia,and simple phobia were four times more common
in patients with joint laxity than in controls.
72A second
case-control study, carried out in psychiatric patients,
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found that joint laxity was 16-times more common in
patients with panic/agoraphobia than in controls.
73
Before embarking on a linkage study in seven extended
families each with many members affected with
panic/phobic disorders and joint laxity, who all came
from a small village near Barcelona, Spain, Estivill’s
group performed a cytogenetic study in 10 patients,
10 in
order to exclude chromosomal rearrangements in their
patients.A putative alteration on chromosome 15 was
identified, consisting of a slight difference in size
between the chromosome homologs, together with a
different G-banding pattern at 15q24-26 in some
metaphases.Further molecular analysis of this chromo-
some region using fluorescent in situ hybridization
(FISH) revealed an interstitial duplication at 15q24-26
(named DUP25).FISH analysis of all available samples
found the duplication in 72% of patients.They then ana-
lyzed the DUP25 in three control groups and detected
it in 6% of samples.The authors then went on to look
for the duplication in a set of 70 unrelated patients with
phobias and found it in 68 subjects.This degree of asso-
ciation is one of the strongest reported for a psychiatric
disorder and a genetic polymorphism.There are, how-
ever, many questions that require further clarity, and
which additional studies may answer.For example,what
is surprising is the broad clinical classification of the
anxiety disorders in the patients with the DUP25.From
the description of the patients, one could assume that
there is a common genetic predisposition to all types of
phobia, which other studies do not support.The other
surprising finding was the complete lack of linkage
between the phenotype and DNA markers that flank or
are contained within the duplication. Gratacòs et al
10
explain this to be a result of the nonmendelian segre-
gation of the duplication within families, since the seg-
regation of the duplication in families is far from sim-
ple. Cases of de novo duplication, reversion from
duplicated to nonduplicated chromosomes, and the
apparent conversion from one form of the duplication
to another were all observed within families.The dupli-
cation also exhibits mosaicism, in that it is not present
in all cells analyzed.The authors propose that the mech-
anism by which the 15q24-26 duplication leads to panic
and phobic disorders and joint laxity is probably
through a dosage effect,with the overexpression of one
or several genes present in the duplicated region;how-
ever,we will have to await further studies to shed more
light on this association.
Animal models of anxiety
A complementary approach to genetic studies of anxi-
ety and related disorders in humans involves the inves-
tigation of genes and their protein products implicated
in the brain neurocircuitry of fear and anxiety in animal
models.Anxiety is one of the psychiatric syndromes best
suited to analogy with animal states. It is well under-
stood that fear, escape, or avoidance behavior, and
panic-like responses are ubiquitous throughout animal
phylogeny, and as Gorman et al
74 have posited, it takes
relatively little intuition to recognize that a rodent that
avoids entering a cage in which adverse stimulus has
been presented in the past, emulates a phobic patient
avoiding a situation that has previously elicited a panic
attack.However,as the same authors caution,
74 the anal-
ogy of panic attacks to animal fear and avoidance
responses “is to be sure,imperfect.”Most animal models
of anxiety states involve conditioning,and it is not at all
clear that PD or any other anxiety disorder except
PTSD involves prior exposure to any aversive stimulus.
Nevertheless,there are many aspects of conditioned fear
in animals that make the analogy with human pheno-
types (eg,panic attacks) irresistible,and thus validate the
pursuit of genetic studies in model animals.
The mouse has long been regarded as an optimal model
system for mammalian genetics.High-resolution genetic
maps,large sets of highly polymorphic markers,and the
availability of inbred strains of genetically identical mice
can now be combined with transgenic and gene-target-
ing technologies that permit the direct manipulation of
the mouse genome. The availability of inbred strains
eliminates trait variation due to differences in genetic
background, and the ability to sample multiple, essen-
tially identical individuals permits assessment of subtle
interstrain differences in the expression of complex
traits.At the same time,the number of valid and reliable
mouse behavioral testing paradigms is rapidly expand-
ing and these can be used to assess many aspects of
behavioral capability.
A number of studies have now indicated that quantita-
tive trait loci on specific chromosomes are associated
with heightened emotionality and with fear-condition-
ing in rodents. For example, Flint et al
75 showed that
three loci on mouse chromosomes 1, 12, and 15 were
associated with decreased activity and increased defe-
cation in a novel environment.They concluded that these
loci were responsible for heightened “emotionality”andspeculated that the genetic basis of emotionality is similar
in other species,and may underlie the psychological trait
of susceptibility to anxiety in humans.In two studies,
76,77
quantitative trait loci on several chromosomes were
found to be associated with contextual fear conditioning
in rodents, and chromosome 1 was implicated in both
studies.The fact that loci on chromosome 1 have been
highlighted in three studies working on such different
measures of the same trait is encouraging.
78 On the basis
of the increasing evidence that genetic variability in
expression and function of proteins that regulate brain
neurotransmitter systems (eg, receptors, ion channels,
transporters, and enzymes) is associated with complex
behavioral traits,research is also emphasizing the mole-
cular psychobiological basis of anxiety-related behavior
in rodents,and increasingly in nonhuman primates.
25
Conclusion
Anxiety disorders belong to the category of complex dis-
eases for which intense research efforts are focused on
the identification of genetic susceptibility factors.
Emerging tools and technologies for genetic analysis will
provide the groundwork for an advanced stage of gene
identification and functional studies in anxiety and related
disorders.More than 1.4 million single nucleotide poly-
morphisms (SNPs) have been identified in the human
genome.This collection should allow the initiation of
genome-wide linkage disequilibrium mapping of genes
influencing anxiety in the human population.
The duplication of part of chromosome 15 is probably a
major genetic factor of susceptibility for panic and phobic
disorders, and its identification may have important
implications for psychiatry and health.If the findings of
Gratacòs et al
10 are confirmed, and the duplication is
shown to segregate in a nonmendelian fashion, it then
suggests another line of investigation for complex dis-
orders. Large-scale chromosomal rearrangements are
common enough in pericentromeric regions for cytoge-
neticists to ignore size variation as an irrelevant poly-
morphism; however, in the future they will perhaps be
assigned greater importance.Complex repeat regions at
the ends of chromosomes also show size variation,
involving hundreds of kilobases of DNA,some of which
may contain functional genes.
79,80
What holds great promise for the future is the increasing
development of techniques that alter or inactivate gene
expression.Whereas in the past, genes could be inacti-
vated (knocked out) from the embryological stage
throughout the life span of the animal, conditional
mutants allow the regulation of expression of a particular
gene by switching it on or off.
81,82 Thus, one can refine
experiments to a much greater degree by the timing of
the expression of a particular gene.With the achieve-
ment of the sequencing of the human genome, and the
active development of techniques for large-scale mole-
cular genetic analysis of the genome,there is now hope
for the identification of the contribution of particular
genes to the development of these disorders.Eventually,
the nature of the gene products might provide the clues
to novel treatment options. ❏
I am very grateful to Dr Marc-Antoine Crocq for his critical reading of the
manuscript and advice.
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